Nancy Veulemans
Keine laufenden Positionen mehr
Karriereverlauf von Nancy Veulemans
Ehemalige bekannte Positionen von Nancy Veulemans
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | General Counsel | 01.01.2005 | 22.11.2012 |
| Cyanamid International Corp. | Corporate Officer/Principal | - | - |
ClinTrials Research, Inc.
 ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Corporate Officer/Principal | - | - |
| Bristol Myers International Group | Corporate Officer/Principal | - | - |
Ausbildung von Nancy Veulemans
| Université Catholique de Louvain | Graduate Degree |
Statistik
International
| Belgien | 3 |
| Vereinigte Staaten | 3 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| General Counsel | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | Health Technology |
| Bristol Myers International Group | |
ClinTrials Research, Inc.
ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Commercial Services |
| Cyanamid International Corp. |
- Börse
- Insiders
- Nancy Veulemans
- Erfahrung
